Corvus Pharmaceuticals, Inc. (CRVS)
11.50
-0.71
(-5.81%)
USD |
NASDAQ |
May 19, 16:00
11.49
-0.01
(-0.09%)
After-Hours: 04:09
Corvus Pharmaceuticals Total Liabilities (Quarterly) : 12.52M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Savara, Inc. | 45.61M |
| Biogen, Inc. | 10.83B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.20M |
| Shareholders Equity (Quarterly) | 240.68M |
| Debt to Equity Ratio | 0.0035 |
| Current Ratio | 19.81 |
| Net Debt Paydown Yield | 0.00% |